Qi Wang

机构：Target (United States), Soochow University, Fudan University, Wenzhou Medical University, Suzhou Vocational Health College, Zhejiang Taizhou Hospital · ORCID：0000-0003-2044-9238

发表论文 71 篇 · 总被引 2058 次 · h-index 24

代表论文

• Identification of cancer-associated fibroblasts subtypes in prostate cancer (2023 · Frontiers in Immunology · 被引 45)
• Microbiota-derived butyrate alleviates asthma via inhibiting Tfh13-mediated IgE production (2025 · Signal Transduction and Targeted Therapy · 被引 42)
• ADORA2A-driven proline synthesis triggers epigenetic reprogramming in neuroendocrine prostate and lung cancers (2023 · Journal of Clinical Investigation · 被引 30)
• Painful diabetic neuropathy: The role of ion channels (2024 · Biomedicine & Pharmacotherapy · 被引 27)
• The ELAVL3/MYCN positive feedback loop provides a therapeutic target for neuroendocrine prostate cancer (2023 · Nature Communications · 被引 20)
• Oxalate‑induced renal pyroptotic injury and crystal formation mediated by NLRP3‑GSDMD signaling in vitro and in vivo (2023 · Molecular Medicine Reports · 被引 17)